Aaron Nilhas, MD
Surgery · Wichita, KSNPI 1336401082
Payments from drug & device makers
What this record shows
AbbVie accounts for 83.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $4,423 and has fallen 90.7% since, to $410 in 2025.
Across 85 payments — averaging $102.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Johnson & Johnson$328
- Davol Inc.$257
- TELA Bio, Inc.$217
- Stryker$188
- Boston Scientific$119
- plus $312 from 12 others
What the payments were for
- Travel & lodging$4,36050%
- Food & beverage$4,37150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $7,311 |
| Johnson & Johnson | 7 | $328 |
| Davol Inc. | 5 | $257 |
| TELA Bio, Inc. | 4 | $217 |
| Stryker | 2 | $188 |
| Boston Scientific | 1 | $119 |
| Smith+Nephew | 3 | $57 |
| Olympus America Inc. | 2 | $51 |
| Shire North American Group Inc | 2 | $36 |
| Vertex | 1 | $31 |
| Intuitive Surgical | 1 | $25 |
| Conmed Corporation | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Merck | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Medline Industries LP | 1 | $16 |
| Bolton Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,731 in reported general payments places this provider in the 80th percentile of 271 surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 284 | $1,612 |
| Oxycodone Hcl | 203 | $559 |
| Sucralfate | 31 | $421 |
| Omeprazole | 26 | $147 |
| Neomycin Sulfate | 16 | $76 |
| Ondansetron OdtOndansetron | 11 | $53 |
| Metronidazole | 20 | $46 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $23 |
| Tramadol Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other surgery in Wichita
- Jeremy HowesWichita$111K
- Bradon BitterWichita$33K
- Nicholas BrownWichita$29K
- Scott PorterWichita$17K
- Sarah CornWichita$15K
- Craig SudbeckWichita$11K
- David GranthamWichita$10K
- Ronald NoldWichita$8K
- Austin GeorgeWichita$8K
- Omar HasanWichita$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.